• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Chris Newmarker

BrightInsight raises $101M for its pre-built digital health platform

March 30, 2021 By Chris Newmarker

BrightInsight

BrightInsight announced today that it’s raised $101 million in a Series C round led by VC firm General Catalyst. The money will go toward more hiring and further accelerating the work BrightInsight is conducting with customers to support their digital health product launches. The San Jose, Calif.–based company offers a turnkey digital health platform for […]

Filed Under: Contract Services, Featured, Funding Roundup, mHealth (Mobile Health), Patient Monitoring, Research & Development Tagged With: BrightInsight, General Catalyst

Dexcom promotes Jereme Sylvain to CFO

March 23, 2021 By Chris Newmarker

Dexcom updated logo

Dexcom (NASDAQ: DXCM) announced today that it has promoted Jereme Sylvain to become a new EVP and CFO at the continuous glucose monitoring company. Sylvain — who joined Dexcom in 2018 and was most recently SVP of finance and chief accounting officer — will report to COO Quentin Blackford. Previously, Blackford had been serving as […]

Filed Under: Business/Financial News, Diabetes, Featured, Personnel Tagged With: CGM, continuous glucose monitor, Dexcom, Personnel Moves

Vertex Pharmaceuticals wins FDA fast track designation for its cell-based diabetes treatment

March 10, 2021 By Chris Newmarker

Vertex Pharmaceuticals

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today that FDA has granted fast track designation for its VX-880, an investigational human stem cell-derived islet cell therapy for type 1 diabetes. Vertex has begun a clinical trial for VX-880 (formerly known as STx-02) in patients with type 1 diabetes (T1D) with severe hypoglycemia and impaired hypoglycemic awareness. “Ours […]

Filed Under: Clinical Trials, Diabetes, Featured, Pharmaceuticals Tagged With: Vertex Pharmaceuticals

Baxter to make Moderna COVID-19 vaccine in US

March 9, 2021 By Chris Newmarker

Baxter Moderna

Baxter announced that its Baxter BioPharma Solutions business will make Moderna‘s COVID-19 vaccine at its fill/finish sterile manufacturing facilities in Bloomington, Ind. The plan — announced yesterday — is for Baxter to make 60–90 million doses of the Moderna vaccine in 2021. “We have seen a remarkable demonstration of scientific and health care expertise in […]

Filed Under: Contract Services, Featured Tagged With: Baxter, coronavirus, COVID-19, Moderna

Boston Scientific to expand its Maple Grove, Minn. campus

March 8, 2021 By Chris Newmarker

Boston Scientific Maple Grove

Boston Scientific (NYSE:BSX) is planning a fourth building at its Maple, Grove, Minn. campus to support expanded nitinol stent manufacturing. The Maple Grove Planning Commission is scheduled to review project plans tonight for the roughly 76,000 ft2 building. “This new building will allow for movement of some production currently taking place in existing buildings on that campus, […]

Filed Under: Business/Financial News, Featured, Stents Tagged With: Boston Scientific, Minnesota

Dexcom Q4 earnings miss by a penny — but revenue up 23%

February 12, 2021 By Chris Newmarker

Dexcom updated logo

Dexcom (NSDQ:DXCM) reported mixed Q4 2020 results and reiterated a fiscal year 2021 revenue guidance that is slightly below Wall Street projections. The San Diego–based continuous glucose monitor company yesterday evening reported profits of $355.2 million, or $3.48 per share, on sales of $568.9 million for the three months ended Dec. 31, 2020, nearly quadrupling the […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: CGM, Dexcom, DexCom Inc., Diabetes

BD stock up on Street-beating preliminary quarterly revenue numbers

January 12, 2021 By Chris Newmarker

BD-logo-new

Becton Dickinson (NYSE:BDX) today announced that it brought in $5.3 billion in revenue for its first quarter ended Dec. 31, 2020, beating the nearly $4.7 billion expected by Wall Street analysts. The announcement of the preliminary unaudited Q1 results sent BDX shares up 1.8% to $261.75 apiece by midday trading today. MassDevice’s MedTech 100 Index, which includes […]

Filed Under: Business/Financial News, Featured Tagged With: BD, Becton Dickinson

BREAKING: BD orders for COVID-19 vaccine injection devices surpass 1 billion

December 16, 2020 By Chris Newmarker

BD logo

Becton Dickinson (NYSE:BDX) announced today that orders have surpassed 1 billion for syringes and needles needed to deliver COVID-19 vaccines. The Franklin Lakes, N.J.–based medtech giant now has commitments from governments in countries including the United States, Australia, Belgium, Canada, Germany, Netherlands, Saudi Arabia, Spain and the United Kingdom. BD has already delivered more than 300 […]

Filed Under: Drug-Device Combinations, Featured Tagged With: BD, coronavirus, COVID-19, syringes

BD is playing a crucial role delivering COVID-19 vaccines: Here’s how

December 15, 2020 By Chris Newmarker

BD needles syringes

Hundreds of millions of vaccine doses will require hundreds of millions of syringes from companies such as BD. As much-hoped-for COVID-19 vaccines roll out to the public, Becton Dickinson (NYSE:BDX) faces an arguably impressive challenge: The Franklin Lakes, N.J.–based medtech giant already has commitments to provide more than 800 million needles and syringes to deliver future COVID-19 […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: BD, coronavirus, COVID-19, syringes

Canada approves Tandem Diabetes Caree’s advanced hybrid closed-loop insulin pump

November 23, 2020 By Chris Newmarker

Tandem Diabetes Care

Tandem Diabetes Care (NSDQ:TNDM) announced today that Health Canada has approved its t:slim X2 insulin pump with Control-IQ technology. The news comes nearly a year after the U.S. launch of the t:slim X2 with Control-IQ. All in-warranty t:slim X2 pump users in Canada will be able to add Control-IQ technology to their existing pump via a […]

Filed Under: Diabetes, Featured Tagged With: Health Canada, insulin, Tandem Diabetes Care

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 9
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS